InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Pierce Christopher, Chief Executive Officer. Officer active across 1 companies, notably Prelude Therapeutics Inc. In total, 2 filings have been published. The latest transaction was disclosed on 2 September 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€183,93517,000 shares@ €10.81970.052% mcap100.0% of flow
Common Stock
SEC:0001209191-21-055072·
€183,93517,000 shares@ €10.81970.052% mcap50.0% of flow
Common Stock
SEC:0001209191-21-055072:0·
2 of 2 declarations
About Pierce Christopher
Christopher Pierce is the Executive Vice President and Chief of Business Operations of Prelude Therapeutics Inc. He oversees business operations and contributes to the company's strategy.
